100 related articles for article (PubMed ID: 8919544)
1. Sequence analysis of the DNA binding domain of the estrogen receptor gene in ER (+)/PR (-) breast cancer.
Mies C; Voigt W
Diagn Mol Pathol; 1996 Mar; 5(1):39-44. PubMed ID: 8919544
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.
Truin W; Roumen RMH; Siesling S; van de Vijver KK; Tjan-Heijnen VCG; Voogd AC
Breast Cancer Res Treat; 2017 Jul; 164(1):133-138. PubMed ID: 28365833
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of a 55 kDa nuclear protein (nmt55) in estrogen receptor-negative human breast cancer.
Traish AM; Huang YH; Ashba J; Pronovost M; Pavao M; McAneny DB; Moreland RB
Diagn Mol Pathol; 1997 Aug; 6(4):209-21. PubMed ID: 9360842
[TBL] [Abstract][Full Text] [Related]
4. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH
Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530
[TBL] [Abstract][Full Text] [Related]
5. Expression and regulation of retinoid-inducible gene 1 (RIG1) in breast cancer.
Shyu RY; Chang SC; Yu JC; Hsu SJ; Chou JM; Lee MS; Jiang SY
Anticancer Res; 2005; 25(3c):2453-60. PubMed ID: 16080475
[TBL] [Abstract][Full Text] [Related]
6. Measurement of ER and PR status in breast cancer using the QuantiGene2.0 assay.
Chae BJ; Bae JS; Yim HW; Lee A; Song BJ; Jeon HM; Chun MH; Jung SS
Pathology; 2011 Apr; 43(3):248-53. PubMed ID: 21436635
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and progesterone receptor mRNA levels in primary breast cancer: association with patient survival and other clinical and tumor features.
Nagai MA; Marques LA; Yamamoto L; Fujiyama CT; Brentani MM
Int J Cancer; 1994 Nov; 59(3):351-6. PubMed ID: 7927940
[TBL] [Abstract][Full Text] [Related]
8. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes.
Pirouzpanah S; Taleban FA; Mehdipour P; Sabour S; Atri M
Cancer Biomark; 2018 Feb; 21(3):621-638. PubMed ID: 29278880
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype.
Schroth W; Winter S; Büttner F; Goletz S; Faißt S; Brinkmann F; Saladores P; Heidemann E; Ott G; Gerteis A; Alscher MD; Dippon J; Schwab M; Brauch H; Fritz P
Breast Cancer Res Treat; 2016 Jan; 155(1):85-97. PubMed ID: 26650824
[TBL] [Abstract][Full Text] [Related]
11. Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer.
Magdelénat H; Gerbault-Seureau M; Dutrillaux B
Int J Cancer; 1994 Apr; 57(1):63-6. PubMed ID: 8150542
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
[TBL] [Abstract][Full Text] [Related]
13. Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.
Boonyaratanakornkit V; Hamilton N; Márquez-Garbán DC; Pateetin P; McGowan EM; Pietras RJ
Mol Cell Endocrinol; 2018 May; 466():51-72. PubMed ID: 29146555
[TBL] [Abstract][Full Text] [Related]
14. [Expression of oestrogen receptor-beta in invasive breast tumours].
Péter I; Számel I; Péley G
Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast.
Li H; Zhu R; Wang L; Zhu T; Li Q; Chen Q; Wang H; Zhu H
Exp Mol Pathol; 2010 Feb; 88(1):150-5. PubMed ID: 19818761
[TBL] [Abstract][Full Text] [Related]
16. Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma.
Davis LM; Harris C; Tang L; Doherty P; Hraber P; Sakai Y; Bocklage T; Doeden K; Hall B; Alsobrook J; Rabinowitz I; Williams TM; Hozier J
J Mol Diagn; 2007 Jul; 9(3):327-36. PubMed ID: 17591932
[TBL] [Abstract][Full Text] [Related]
17. The loss of estrogen and progesterone receptor gene expression in human breast cancer.
Lapidus RG; Nass SJ; Davidson NE
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):85-94. PubMed ID: 10819507
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue.
Leygue E; Dotzlaw H; Watson PH; Murphy LC
Biochem Biophys Res Commun; 1996 Nov; 228(1):63-8. PubMed ID: 8912636
[TBL] [Abstract][Full Text] [Related]
19. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells.
Lim JT; Joe AK; Suzui M; Shimizu M; Masuda M; Weinstein IB
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3478-84. PubMed ID: 16740773
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Msx2 gene expression by steroid hormones in human nonmalignant and malignant breast cancer explants cultured in vitro.
Malewski T; Milewicz T; Krzysiek J; Gregoraszczuk EL; Augustowska K
Cancer Invest; 2005; 23(3):222-8. PubMed ID: 15945508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
